EA
HAE icon

Emerald Advisers’s Haemonetics HAE Stock Holding History

Emerald Advisers’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-66,108
Closed -$5.47M – 256
2024
Q2 		$5.47M Sell
66,108
-64,329
-49% -$5.66M 0.23% 111
2024
Q1 		$11.1M Sell
130,437
-16,877
-11% -$1.32M 0.45% 90
2023
Q4 		$12.6M Sell
147,314
-4,149
-3% -$359K 0.54% 78
2023
Q3 		$13.6M Sell
151,463
-23,387
-13% -$2.09M 0.66% 70
2023
Q2 		$14.9M Buy
174,850
+371
+0.2% +$31.4K 0.65% 71
2023
Q1 		$14.4M Sell
174,479
-1,695
-1% -$137K 0.69% 68
2022
Q4 		$13.9M Sell
176,174
-145,097
-45% -$11.7M 0.67% 69
2022
Q3 		$23.8M Buy
321,271
+89
+0% +$6.39K 1.23% 25
2022
Q2 		$20.9M Buy
321,182
+53,634
+20% +$3.17M 1.08% 29
2022
Q1 		$16.9M Buy
+267,548
New +$14.5M 0.64% 65
2020
Q3 		– Sell
-87,835
Closed -$7.87M – 344
2020
Q2 		$7.87M Sell
87,835
-186,315
-68% -$18.8M 0.34% 98
2020
Q1 		$27.3M Buy
274,150
+25,630
+10% +$2.78M 1.58% 15
2019
Q4 		$28.6M Buy
248,520
+44,880
+22% +$5.43M 1.21% 21
2019
Q3 		$25.7M Buy
203,640
+22,470
+12% +$2.85M 1.2% 27
2019
Q2 		$21.8M Buy
181,170
+24,410
+16% +$2.4M 0.88% 42
2019
Q1 		$13.7M Buy
156,760
+28,153
+22% +$2.56M 0.56% 70
2018
Q4 		$12.9M Buy
+128,607
New +$13.5M 0.63% 64

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return

Emerald Advisers's HAE Position: Q3 2024 in Review

Emerald Advisers sold out of Haemonetics (HAE) in Q3 2024, closing a stake of 66,108 shares — an estimated $5.47M sold.

Emerald Advisers first reported a position in HAE in Q4 2018 and held it in 17 quarters. The position peaked at $28.6M in Q4 2019. 306 funds tracked by Wall St. Rank hold HAE as of Q3 2024.

  • Emerald Advisers reported no remaining Haemonetics position as of Q3 2024 after selling out during the quarter.
  • Emerald Advisers sold 66,108 Haemonetics shares in Q3 2024, an estimated $5.47M.
  • Emerald Advisers first reported a position in Haemonetics in Q4 2018 and held it in 17 quarters.
  • Emerald Advisers's Haemonetics position peaked at $28.6M in Q4 2019.
  • 306 funds tracked by Wall St. Rank held Haemonetics as of Q3 2024.

Based on Emerald Advisers's 13F filing for Q3 2024, filed 29 Oct 2024.